// App-Quantinova.ai

PB2417 : Sodium Valproate-induced Drug Interactions with DOAC Anticoagulant Activity: A Case Report

Researchers

Presenter

  • I. Paskaleva

Principal Investigators

  • E. Doncheva

  • R. Simeonova

  • V. Ignatova

  • A. Dramov

Medical Centers

  • National Heart Hospital, Laboratory Diagnostics Department, Sofia, Bulgaria

  • Pharmaceutical Faculty, Medical University, Department of Pharmacology, Pharmacotherapy and Toxicology, Sofia, Bulgaria

  • National Heart Hospital - Department of Cardiology 1, Sofia, Bulgaria

  • National Heart Hospital - Department of Cardiology 1, Sofia, Bulgaria

Locations

  • Bulgaria

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

Disease

  • Post-traumatic seizures

  • Venous thrombosis

  • Epilepsy

Biomarkers

  • Prothrombin

Drug/Treatment

  • Sodium valproate

  • rivaroxaban

  • Valproate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved